Influenza ("flu") is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. Influenza can range from a mild to severe illness and may result in hospitalization or death, particularly in vulnerable individuals. Influenza viruses spread primarily through respiratory droplets generated when infected individuals cough, sneeze, speak, or breathe in close proximity to others. Transmission may also occur through contact with contaminated surfaces followed by touching the eyes, nose, or mouth.
Travel Guard recommends that all travellers familiarize themselves with the common signs and symptoms of influenza and seek medical advice promptly if symptoms develop.
Common symptoms include:
Some individuals are at increased risk of serious illness, hospitalization, or complications from influenza. These include:
Travelers within these groups should exercise particular caution and seek medical advice promptly if influenza is suspected.
Annual influenza vaccination remains the most effective method of reducing the risk of influenza infection and its complications. Public health authorities recommend vaccination for all individuals aged six months and older unless medically contraindicated. Vaccination is particularly important for those at increased risk of severe illness.
Influenza viruses continually evolve, and vaccine formulations are reviewed and updated annually by the World Health Organization (WHO) and national health authorities to provide protection against the strains most likely to circulate during the upcoming influenza season.
Children younger than six months cannot receive influenza vaccination and rely on the vaccination of parents, caregivers, family members, and healthcare workers for indirect protection.
Individuals with suspected influenza who are at increased risk of complications, have severe symptoms, or require hospitalization should seek medical attention as soon as possible.
Healthcare providers may prescribe antiviral medications, which can:
Antiviral treatment is most effective when started within 48-hours of symptom onset; however, treatment may still provide benefit in high-risk patients and hospitalized individuals even when initiated later. Clinicians may begin treatment based on clinical suspicion without waiting for laboratory confirmation.
Current approved antiviral medications may include:
The choice of antiviral medication should be determined by the treating healthcare provider.
Travel Guard recommends the following measures to reduce the risk of influenza infection while traveling:
Influenza remains a significant global health concern and continues to cause substantial illness, hospitalizations, and deaths each year. Annual vaccination, good hand hygiene, respiratory etiquette, and timely medical assessment for high-risk individuals remain the cornerstones of influenza prevention and management.
· Centers for Disease Control and Prevention (CDC) – Influenza (Flu) Guidance and Prevention Information. [cdc.gov]
· CDC – People at Increased Risk for Flu Complications. [cdc.gov]
· World Health Organization (WHO) – Treating Flu with Antiviral Drugs. [who.int]
· WHO – Influenza Antiviral Medications: Summary for Clinicians. [who.int]
· WHO – Recommendations for Influenza Vaccine Composition 2025–2026. [who.int]